Skip Navigation



ToxSci Advance Access published online on April 14, 2004

Toxicological Sciences, doi:10.1093/toxsci/kfh146
Toxicological Sciences © Society of Toxicology 2004; all rights reserved
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
80/1/203    most recent
kfh146v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Luyendyk, J. P.
Right arrow Articles by Roth, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luyendyk, J. P.
Right arrow Articles by Roth, R. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received February 26, 2004; accepted April 2, 2004
© 2004 Toxicological Sciences © Society of Toxicology 2004; all rights reserved.

Systems Evaluation

Gene Expression Analysis Points to Hemostasis in Livers of Rats Cotreated with Lipopolysaccharide and Ranitidine

James P. Luyendyk 1, William B. Mattes 2, Lyle D. Burgoon 1, Timothy R. Zacharewski 3, Jane F. Maddox 1, Gregory N. Cosma 2, Patricia E. Ganey 1, and Robert A. Roth 1*

1 Department of Pharmacology and Toxicology, National Food Safety and Toxicology Center, Center for Integrative Toxicology, Michigan State University, East Lansing, MI, 48824 USA
2 Investigative Toxicology, Pharmacia Corporation, Kalamazoo, MI, USA
3 Department of Biochemistry and Molecular Biology, National Food Safety and Toxicology Center, Center for Integrative Toxicology, Michigan State University, East Lansing, MI, 48824 USA

* To whom correspondence should be addressed. E-mail: rothr{at}msu.edu.


   Abstract

Studies in rats have demonstrated that modest underlying inflammation can precipitate idiosyncrasy-like liver injury from the histamine 2-receptor antagonist ranitidine (RAN). Coadministration to rats of nonhepatotoxic doses of RAN and the inflammagen, bacterial lipopolysaccharide (LPS), results in hepatocellular injury. We tested the hypothesis that hepatic gene expression changes could distinguish Vehicle-, LPS-, RAN- and LPS/RAN-treated rats before the onset of significant liver injury in LPS/RAN-treated rats (i.e., 3 h post-treatment). Rats were treated with LPS (44 x 106 EU/kg, iv) or its vehicle, then two hours later with RAN (30 mg/kg, iv) or its vehicle. They were killed 3 h after RAN treatment, and liver samples were taken for evaluation of liver injury and RNA isolation. Hepatic parenchymal cell injury, as estimated by increases in serum alanine aminotransferase (ALT) activity, was not significant at this time. Hierarchical clustering of gene expression data from Affymetrix U34A rat genome arrays grouped animals according to treatment. Relative to treatment with vehicle alone, treatment with RAN and/or LPS altered hepatic expression of numerous genes, including ones encoding for products involved in inflammation, hypoxia, and cell death. Some of them were enhanced synergistically by LPS/RAN cotreatment. Real-time PCR confirmed robust changes in expression of B-cell translocation gene 2, early growth response-1, and plasminogen activator inhibitor-1 (PAI-1) in cotreated rats. The increase in PAI-1 mRNA was reflected in an increase in serum PAI-1 protein concentration in LPS/RAN-treated rats. Consistent with the antifibrinolytic activity of PAI-1, significant fibrin deposition occurred only in livers of LPS/RAN-treated rats. The results suggest the possibility that expression of PAI-1 promotes fibrin deposition in liver sinusoids of LPS/RAN-treated rats and are consistent with the development of local ischemia and consequent tissue hypoxia.

Key Words: inflammation, ranitidine, liver, gene array, plasminogen activator inhibitor-1, hypoxia .


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
F. F. Tukov, J. P. Luyendyk, P. E. Ganey, and R. A. Roth
The Role of Tumor Necrosis Factor Alpha in Lipopolysaccharide/Ranitidine-Induced Inflammatory Liver Injury
Toxicol. Sci., November 1, 2007; 100(1): 267 - 280.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. P. Luyendyk, L. D. Lehman-McKeeman, D. M. Nelson, V. M. Bhaskaran, T. P. Reilly, B. D. Car, G. H. Cantor, X. Deng, J. F. Maddox, P. E. Ganey, et al.
Coagulation-Dependent Gene Expression and Liver Injury in Rats Given Lipopolysaccharide with Ranitidine but Not with Famotidine
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 635 - 643.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. P. Luyendyk, L. D. Lehman-McKeeman, D. M. Nelson, V. M. Bhaskaran, T. P. Reilly, B. D. Car, G. H. Cantor, J. F. Maddox, P. E. Ganey, and R. A. Roth
Unique Gene Expression and Hepatocellular Injury in the Lipopolysaccharide-Ranitidine Drug Idiosyncrasy Rat Model: Comparison with Famotidine
Toxicol. Sci., April 1, 2006; 90(2): 569 - 585.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. P. Luyendyk, P. J. Shaw, C. D. Green, J. F. Maddox, P. E. Ganey, and R. A. Roth
Coagulation-Mediated Hypoxia and Neutrophil-Dependent Hepatic Injury in Rats Given Lipopolysaccharide and Ranitidine
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1023 - 1031.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.